<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: CADASIL (cerebral <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">arteriopathy</z:e> subcortical <z:mpath ids='MPATH_124'>infarcts</z:mpath> and <z:hpo ids='HP_0002352'>leukoencephalopathy</z:hpo>) is a <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorder</z:e> hallmarked by <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Characteristic pathological changes in the vasculature include thickening of small arteries and accumulation of <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> material within the vessel wall </plain></SENT>
<SENT sid="2" pm="."><plain>We tested whether endothelial <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (vWF) accumulates in CADASIL vessels and whether exposure of smooth muscle cells to vWF alters the expression of smooth muscle gene expression </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Brain sections obtained at autopsy from six North American CADASIL patients were examined using immunohistochemistry for vWF and IgG </plain></SENT>
<SENT sid="4" pm="."><plain>Rat aortic smooth muscle cells (A7R5 cells) were tested for binding to infrared-tag labeled vWF </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, A7R5 cells were exposed to vWF, and expression of mature smooth muscle marker genes was analyzed by quantitative reverse transcriptase PCR </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: vWF is expressed in the penetrating arterial walls in <z:hpo ids='HP_0000001'>all</z:hpo> CADASIL samples </plain></SENT>
<SENT sid="7" pm="."><plain>IgG, a marker of serum extravasation, was present only in a minority of arterial walls </plain></SENT>
<SENT sid="8" pm="."><plain>vWF binds to smooth muscle cells in vitro, and low concentrations of vWF rapidly activate c-fos, EGR, TSP1, and c-myc while specifically inhibiting <z:chebi fb="40" ids="33697">RNA</z:chebi> encoding smooth muscle actin, calponin, and SM22 </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: These data demonstrate that vWF, likely produced by the endothelium, permeates the vessel wall of CADASIL brains </plain></SENT>
<SENT sid="10" pm="."><plain>Exposure of smooth muscle cells to vWF results in reduction of specific <z:chebi fb="40" ids="33697">RNAs</z:chebi> required for <z:mpath ids='MPATH_458'>normal</z:mpath> vascular homeostasis </plain></SENT>
<SENT sid="11" pm="."><plain>This is the first report of accumulation of a protein within CADASIL vessels that inhibits vascular gene expression and implicates a role for vWF beyond hemostasis </plain></SENT>
</text></document>